Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
92.2M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
3.88M
-
Shares change
-
-353K
-
Total reported value, excl. options
-
$2.54M
-
Value change
-
-$384K
-
Number of buys
-
11
-
Number of sells
-
-12
-
Price
-
$0.65
Significant Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) as of Q4 2022
29 filings reported holding CNTX - Context Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.88M shares
of 92.2M outstanding shares and own 4.21% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (1.14M shares), Affinity Asset Advisors, LLC (884K shares), VANGUARD GROUP INC (641K shares), Worth Venture Partners, LLC (282K shares), swisspartners Ltd. (180K shares), HighTower Advisors, LLC (126K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (106K shares), RENAISSANCE TECHNOLOGIES LLC (105K shares), Mill Creek Capital Advisors, LLC (105K shares), and GEODE CAPITAL MANAGEMENT, LLC (61.2K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.